Dorsey & Whitney Trust’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$365K Buy
1,724
+6
+0.3% +$1.18K 0.02% 522
2026
Q1
$337K Sell
1,718
-18
-1% -$3.5K 0.02% 532
2025
Q4
$301K Sell
1,736
-24
-1% -$4.37K 0.02% 557
2025
Q3
$335K Hold
1,760
– – 0.02% 510
2025
Q2
$316K Buy
1,760
+43
+3% +$7.47K 0.02% 523
2025
Q1
$291K Buy
1,717
+87
+5% +$14.3K 0.02% 526
2024
Q4
$246K Sell
1,630
-7
-0.4% -$1.09K 0.01% 583
2024
Q3
$254K Buy
1,637
+52
+3% +$7.77K 0.01% 575
2024
Q2
$217K Sell
1,585
-96
-6% -$13.1K 0.02% 568
2024
Q1
$224K Buy
1,681
+23
+1% +$2.98K 0.02% 571
2023
Q4
$229K Buy
+1,658
New +$218K 0.02% 535
2023
Q3
– Sell
-1,795
Closed -$252K – 594
2023
Q2
$252K Buy
1,795
+359
+25% +$49.5K 0.02% 485
2023
Q1
$203K Hold
1,436
– – 0.02% 529
2022
Q4
$225K Sell
1,436
-358
-20% -$51.4K 0.02% 497
2022
Q3
$220K Buy
+1,794
New +$236K 0.02% 484
2022
Q1
– Sell
-1,348
Closed -$233K – 576
2021
Q4
$233K Buy
+1,348
New +$205K 0.02% 487
2021
Q1
– Sell
-1,722
Closed -$205K – 528
2020
Q4
$205K Buy
+1,722
New +$210K 0.02% 442

Other funds holding DGX

Dorsey & Whitney Trust's DGX Position: Q2 2026 in Review

Dorsey & Whitney Trust increased its Quest Diagnostics (DGX) stake by 0.35% in Q2 2026, buying an estimated $1.18K and bringing the position to 1,724 shares worth $365K. The position accounts for 0.02% of the portfolio, ranked #522.

Dorsey & Whitney Trust first reported a position in DGX in Q4 2020 and has held it in 17 quarters since. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Dorsey & Whitney Trust held 1,724 shares of Quest Diagnostics worth $365K as of Q2 2026.
  • Dorsey & Whitney Trust bought 6 Quest Diagnostics shares in Q2 2026, an estimated $1.18K.
  • Quest Diagnostics made up 0.02% of Dorsey & Whitney Trust's portfolio in Q2 2026, its #522 holding.
  • Dorsey & Whitney Trust first reported a position in Quest Diagnostics in Q4 2020 and has held it in 17 quarters since.
  • 1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Dorsey & Whitney Trust's 13F filing for Q2 2026, filed 14 Aug 2026.